Abranilla, Baby Girl .
HRN: 26-63-00 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/06/2025
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
03/06/2025
03/12/2025
ORAL
0.75ml
Q12
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes